阿尔茨海默病的炎症机制及其非甾体类消炎药临床应用前景被引量：3

下载PDF

导出

摘要从流行病学、病理学、免疫学、生物化学、分子生物学以及临床的角度综述近几年关于阿尔茨海默病 (AD)炎症机制的研究进展 ,同时展望非甾体类消炎药 (NSAIDs)

作者徐武华

机构地区暨南大学医学院第四附属医院

出处《广东药学院学报》 CAS 2001年第4期310-312,共3页 Academic Journal of Guangdong College of Pharmacy

关键词阿尔茨海默病炎症发病机制非甾体类消炎药

同被引文献24

1刘佳福,刘振国.阿尔茨海默病炎症发病机制的研究进展[J].中风与神经疾病杂志,2004,21(5):471-472. 被引量：4
2O'banion Mk, Finch CE.Inflammatory mechanisms and anti-inflammatory therapy in Alzheimer's disease,neurobiol a-ging[J], 1996; 17 (5):669
3Veld BA, Ruitenberg A, Hofinan A, et al .Nonste roe dal antiflammatory drugs and the risk of Alzheimer's disease [J].N EnA J Nkd ,2001;345(21): 1515
4盛树力.老年痴呆分子生物学到临床诊治[M].北京:科学技术文献出版社,1999:128-135.
5Khan TK, Alkon DI.An internally controlled peripheral biomarker for Alzheimer's disease:Erkl and Erk2 respomes to the inflammatory signal bradykinin [J]. Proc Natl Acad Sci U S A,2006,103(35): 13203-13207
6Khan TK,Alkon DI.An internally controlled peripheral biomarker for Alzheimer's disease:Erk1 and Erk2 responses to the inflammatory signal bradykinin[J].Proc Natl Acad Sci U S A,2006,103(35):13203-13207.
7O'banion Mk,Finch CE.inflammatory mechanisms and anti-inflammatory therapy in alzheimer's disease,neurobiol aging[J],1996:17 (5):669-671.
8Veld BA,Ruitenberg A,Hofman A,et al.Nonsteroedal antiflammatory drugs and the risk of Alzheimer's disease[J].N EnA J Nkd,2001,345(21):1515-1521.
9[2]Pocock JM, Liddle AC. Microglial signalling cascades in neurodegenerative disease [J]. Prog Brain Res,2001,132:555～565
10[3]Brod SA. Unregulated inflammation shortens human functional longevity[J]. Inflamm Res,2000,49: 561～570

1王玲,黄兆胜.中医药对Alzheimer病免疫系统干预途径的探讨[J].中医药学刊,2004,22(11):2116-2118.
2唐大春,刘明华,章卓,秦大莲,肖顺汉,邓莎.阿司匹林与黄芪颗粒合用对大鼠Alzheimer's病治疗作用研究[J].泸州医学院学报,2009,32(1):18-21.
3章卓,刘明华,秦大莲,肖顺汉,李华.阿司匹林与黄芪颗粒合用对大鼠Alzheimer’s模型炎症因子影响研究[J].四川生理科学杂志,2009,31(1):9-11. 被引量：6

广东药学院学报

2001年第4期

内容加载中请稍等...